Learn about GAMUNEX-C, a CIDP, and PIDD treatment option, its efficacy, safety information and patient support. |GAMUNEX®-C (immune globulin injection [human], 10% caprylate/chromatography purified)
GAMUNEX-C is a formulation that blocks the autoimmune and inflammatory processes that cause nerve damage in chronic inflammatory demyelinating polyneuropathy (CIDP).4,5 GAMUNEX-C can help5: Improve the symptoms of CIDP Prevent further nerve damage Reduce the likelihood of relapse Learn more Stories...
GAMUNEX-C is an immune globulin injection (human) 10% liquid • CIDP – The most common adverse reactions during clinical indicated for treatment of: trials (reported in Ն5% of subjects) were headache, fever, • Primary Humoral Immunodeficiency (PI) chills, hypertension, rash, nausea and...
GAMUNEX-C is an immune globulin injection (human) 10% liquid that is indicated for the treatment of: 1.1 Primary Humoral Immunodeficiency (PI) GAMUNEX-C is indicated for treatment of primary humoral immunodeficiency in patients 2 years of age and older. This includes, but is not limited to, ...
It is not known whether Gamunex-C can cause fetal harm when administered to a pregnant woman. Therefore, Gamunex-C should be given to a pregnant woman only if clearly needed. The use of Gamunex-C has not been evaluated in nursing mothers. ...
FDA批准Talecris Biotherapeutics公司Gamunex-C[免疫球蛋白注射液(人用),10%辛酸酯/色谱纯化]用于皮下注射,治疗原发性免疫缺陷(primary immunodeficiency,PI)。皮下给药途径的获批是对已经获批的用于治疗PI和其他两种适应症(慢性炎性脱髓鞘性多神经病和特发性血小板减少性紫癜)的静脉给药途径的补充。 关键词: 原发性...
GAMUNEX®-C (immune globulin injection [human], 10% caprylate/chromatography purified) is indicated for the treatment of primary humoral immunodeficiency disease (PIDD) in patients 2 years of age and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory ...